Abstract |
Fifteen Hodgkin's disease patients (8 male, 7 female) aged 19-72 years, who had been in complete unmaintained remission for 1 year or more when the study was initiated, were given 50 mg thymostimulin (TS) IM daily for 60 consecutive days. When compared with 26-30 age- and sex-matched controls, as a group the patients' circulating ENR+, OKT+3, and OKT+4 cells were depressed (0.001 less than or equal to P less than or equal to 0.06), whereas their OKT+8 cell population was not. Low (greater than 1 SD or greater than 2 SD below mean in controls) or borderline (mean value of two subsequent tests greater than 1 SD below mean in controls) values of ENR+, OKT+3, and OKT+4 cells were seen in nine (group I) of the 15 patients tested, while the remaining six patients (group II) had normal T-cell proportions. Following TS treatment, the proportions of ENR+, OKT+3, and OKT+4 cells increased to normal in all group I patients. The T-cell levels, however, decreased to pretreatment values 60-70 days after completion of TS therapy. TS had no effect on the group II patients whose T-cell percentages had initially been normal. Spontaneous cell-mediated cytotoxicity (SCMC) was assessed in 11 patients, and irrespective of the baseline values, there was a significant enhancement (P less than 0.005) by day 15 of TS administration, which was maintained during treatment. SCMC, however, returned to pretreatment levels 60-70 days after TS was discontinued. The delayed skin test reactivity to DNCB was significantly depressed in all cases. Although TS restored the T-cell proportions, it failed to reverse DNCB reactivity from negative to positive in any of the patients tested. TS can thus restore defective T-cell frequencies and can enhance cytolytic functions that are potentially important in host immunosurveillance, but it apparently failed to improve the skin reactivity to neoantigen.
|
Authors | A M Liberati, M Brugia, B S Edwards, P Bertoni, E Ballatori, A Puxeddu, F Grignani |
Journal | Cancer immunology, immunotherapy : CII
(Cancer Immunol Immunother)
Vol. 19
Issue 2
Pg. 136-41
( 1985)
ISSN: 0340-7004 [Print] Germany |
PMID | 3872709
(Publication Type: Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Antigens, Surface
- Thymus Extracts
- thymostimulin
|
Topics |
- Adult
- Aged
- Antibodies, Monoclonal
- Antigens, Surface
(analysis)
- B-Lymphocytes
(immunology)
- Female
- Hodgkin Disease
(drug therapy, immunology)
- Humans
- Hypersensitivity, Delayed
(immunology)
- Lymphocytes
(immunology)
- Male
- Middle Aged
- T-Lymphocytes
(immunology)
- Thymus Extracts
(therapeutic use)
|